Knowledge / Nursing / Diabetes and endocrine nursing

Diabetes and endocrine nursing

Nursing (B.Sc Nursing) · Medical-surgical nursing · free study notes for exams, placements and interviews

In short

Diabetes and endocrine nursing is the medical-surgical care of patients whose hormone-producing glands — pancreatic islets, thyroid, parathyroid, adrenals and pituitary — are over- or under-functioning. It matters because India has roughly 10 crore people with diabetes and an even larger group — about 13.6 crore — with prediabetes (ICMR-INDIAB), so a nurse on any ward will manage insulin, glucose monitoring and foot risk daily, whatever the admitting diagnosis. The topic is examined in INC/university Medical-Surgical Nursing II papers (endocrine unit), in NORCET, AIIMS, JIPMER, state staff-nurse and ESIC recruitment tests, and in interview rounds at Apollo, Fortis, Manipal, AIIMS and district hospitals. Clinically it governs the three true endocrine emergencies — hypoglycaemia, diabetic ketoacidosis and thyroid storm — where nursing action within minutes decides the outcome. It is also the main nursing contribution to NPCDCS/NP-NCD screening and health-and-wellness-centre work under Ayushman Bharat.

Explained

Endocrine physiology a nurse must hold

Diabetes mellitus — classification and diagnosis

Nursing management of diabetes — the four pillars plus education

  1. Diet: carbohydrate 50–60% of energy with complex carbohydrates and 25–30 g fibre, protein 15–20%, fat <30% (saturated <10%), consistent carbohydrate timing with insulin. Practical Indian counselling: smaller rice portion, add dal/curd/vegetables, prefer whole wheat/millets (ragi, jowar, bajra), avoid fruit juice and "sugar-free" sweets eaten freely.
  2. Exercise: 150 minutes/week moderate aerobic plus resistance twice weekly; check glucose before and after; take 15 g carbohydrate if <100 mg/dL; avoid exercise at peak insulin action and when ketones are present; inspect footwear and feet after activity.
  3. Monitoring: self-monitoring of blood glucose (SMBG) with glucometer — side of the fingertip, first drop wiped if hands washed with soap not possible, rotate sites; HbA1c every 3 months until stable then 6-monthly; urine ketones in type 1 when glucose >250 mg/dL or during illness; CGM where affordable.
  4. Pharmacology — nurse's angle:
    • Metformin (biguanide): first line, no hypoglycaemia alone, GI upset, B12 deficiency on long use; hold before contrast studies and in renal impairment/sepsis (lactic acidosis risk).
    • Sulphonylureas (glimepiride, gliclazide): cause hypoglycaemia and weight gain — give with the meal, warn about skipped meals.
    • DPP-4 inhibitors (sitagliptin, teneligliptin), SGLT2 inhibitors (dapagliflozin, empagliflozin — genital mycotic infection, volume depletion, euglycaemic DKA), GLP-1 receptor agonists (liraglutide, semaglutide — nausea, weight loss), pioglitazone (oedema, heart failure), acarbose (flatulence; hypoglycaemia on acarbose must be treated with glucose, not sucrose).
    • Insulins: rapid-acting (lispro, aspart — onset 10–15 min, peak 1–2 h), regular/short (30 min, peak 2–4 h), intermediate NPH (1–2 h, peak 6–12 h, cloudy), long-acting glargine/detemir/degludec (flat, 20–42 h), premixed 30/70. Strength in India is almost entirely U-100; U-40 vials persist in some places, so the syringe must match the vial.
    • Injection technique: subcutaneous at 90° with a 4–6 mm pen needle (no pinch needed for short needles), rotate within one anatomical site — abdomen fastest, then arm, thigh, buttock; when mixing, draw clear (regular) before cloudy (NPH); never shake insulin; roll cloudy insulin; never mix glargine with any insulin; store unopened vials at 2–8 °C, in-use pen at room temperature up to ~28 days, never freeze, never leave on a window sill.
    • Lipohypertrophy from non-rotation causes erratic absorption — palpate sites at every review.
  5. Education and follow-up: sick-day rules (never omit insulin, test 4-hourly, take fluids, check ketones), sharps disposal, carrying 15 g glucose and an identity card, annual dilated fundus examination, urine albumin-creatinine ratio, lipids, foot examination at every visit, vaccination, pre-conception counselling, smoking and alcohol cessation.

Acute complications — the emergencies

Chronic complications and the diabetic foot

Thyroid, parathyroid, adrenal and pituitary nursing

Indian standards, programmes and legal frame

Key points

Formulas and examples

HbA1c → estimated average glucose: eAG (mg/dL) = (28.7 × HbA1c%) − 46.7
Serum osmolality (mOsm/kg) = 2 × [Na⁺] + glucose/18 + BUN/2.8 (Na⁺ in mEq/L; glucose and BUN in mg/dL; normal 275–295)
Anion gap (mEq/L) = [Na⁺] − ([Cl⁻] + [HCO₃⁻]) (normal 8–12; >12 in DKA)
Corrected Na⁺ = measured Na⁺ + 1.6 × (glucose − 100)/100 (mg/dL glucose; corrects pseudohyponatraemia of hyperglycaemia)
Insulin infusion rate (mL/h) = (dose in units/h × volume of bag in mL) / units of insulin in the bag
Insulin unit dose (mL) = ordered units ÷ concentration (units/mL) (U-100 → 100 units/mL)
Total daily insulin dose ≈ 0.5–1.0 unit/kg/day; basal ≈ 40–50%, divided bolus ≈ 50–60%
Correction (sensitivity) factor: 1 unit lowers glucose by 1800 ÷ TDD mg/dL (rapid-acting; 1500 rule for regular insulin)
Insulin-to-carbohydrate ratio: 1 unit per 500 ÷ TDD grams of carbohydrate
IV fluid drip rate (drops/min) = (volume in mL × drop factor) / time in minutes

Example 1 — HbA1c to average glucose. A 52-year-old man's HbA1c is 9.2%.

Example 2 — DKA bedside numbers. Glucose 648 mg/dL, Na⁺ 130 mEq/L, Cl⁻ 96 mEq/L, HCO₃⁻ 8 mEq/L, BUN 28 mg/dL, pH 7.12, K⁺ 3.1 mEq/L.

Example 3 — insulin infusion and syringe dose. A 70 kg patient in DKA is ordered regular insulin 0.1 unit/kg/h from a bag of 50 units in 50 mL normal saline.

Example 4 — correction dose and carbohydrate ratio. Type 1 patient, 60 kg, total daily dose 36 units, pre-lunch glucose 280 mg/dL, target 120 mg/dL, meal 60 g carbohydrate.

Example 5 — fluid resuscitation drip rate. 1,000 mL normal saline over 1 hour with a macro set of drop factor 15 drops/mL.

FeatureHypoglycaemiaDKAHHS
Glucose<70 mg/dLusually >250 mg/dLoften >600 mg/dL
OnsetMinutesHours to 1–2 daysDays to weeks
Typical patientAny, on insulin/sulphonylureaType 1 (or type 2 under stress)Elderly type 2
Ketones / pHAbsent, pH normalKetonaemia, pH <7.3Trace, pH >7.3
BreathingNormalKussmaul, acetone breathNormal
SkinCold, clammy, sweatingWarm, dry, dehydratedVery dry, poor turgor
First action15 g carbohydrate or IV dextroseIV normal salineIV normal saline
FeatureHypothyroidismHyperthyroidism
TSH / free T4High / lowLow / high
Weight, appetiteGain with poor appetiteLoss with good appetite
TemperatureCold intoleranceHeat intolerance, sweating
Pulse, bowelBradycardia, constipationTachycardia/AF, diarrhoea
CrisisMyxoedema comaThyroid storm
DrugLevothyroxine, empty stomachCarbimazole/PTU, beta-blocker

Where it is used

Interview questions

Common mistakes

Related topics

Cardiovascular nursing · Wound care and pressure injuries · Fluid, electrolyte and acid-base balance · Pharmacology and drug calculations · Community health nursing and national health programmes · Nutrition and dietetics in disease.

Open in the Knowledge reader →Find jobs →